Carolinas Wealth Consulting’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-214
| Closed | -$19.1K | – | 1168 |
|
|
2023
Q4 | $19.1K | Hold |
214
| – | – | ﹤0.01% | 451 |
|
|
2023
Q3 | $14.1K | Hold |
214
| – | – | ﹤0.01% | 475 |
|
|
2023
Q2 | $17.8K | Hold |
214
| – | – | ﹤0.01% | 497 |
|
|
2023
Q1 | $16.3K | Hold |
214
| – | – | ﹤0.01% | 529 |
|
|
2022
Q4 | $17.7K | Sell |
214
-1,500
| -88% | -$124K | ﹤0.01% | 520 |
|
|
2022
Q3 | $136K | Hold |
1,714
| – | – | 0.03% | 197 |
|
|
2022
Q2 | $127K | Hold |
1,714
| – | – | 0.03% | 214 |
|
|
2022
Q1 | $154K | Hold |
1,714
| – | – | 0.03% | 200 |
|
|
2021
Q4 | $192K | Hold |
1,714
| – | – | 0.04% | 174 |
|
|
2021
Q3 | $215K | Sell |
1,714
-79
| -4% | -$9.91K | 0.05% | 151 |
|
|
2021
Q2 | $243K | Buy |
1,793
+79
| +5% | +$10.7K | 0.05% | 148 |
|
|
2021
Q1 | $232K | Hold |
1,714
| – | – | 0.06% | 148 |
|
|
2020
Q4 | $241K | Buy |
1,714
+1,501
| +705% | +$211K | 0.06% | 134 |
|
|
2020
Q3 | $24K | Sell |
213
-100
| -32% | -$11.3K | 0.01% | 372 |
|
|
2020
Q2 | $35K | Buy |
+313
| New | +$35K | 0.01% | 237 |
|